Target intelligence / Profile preview

Vaginal ecological niche

Molecular classification
Other
01

Overview

The vaginal ecological niche is a complex biological environment defined by the interaction between the host vaginal epithelium, the local immune system, and a specialized community of microorganisms known as the vaginal microbiota. In healthy women of reproductive age, this niche is typically dominated by Lactobacillus species, which play a critical role in maintaining a low pH (3.5–4.5) through the fermentation of glycogen-derived products into lactic acid (Ravel et al., 2011, PNAS). This acidic environment, supplemented by the production of antimicrobial compounds like hydrogen peroxide and bacteriocins, serves as a primary defense against the colonization of pathogenic organisms (Borges et al., 2014, Arch Gynecol Obstet). Disruption of this ecological balance, often termed dysbiosis, can lead to conditions such as bacterial vaginosis (BV) and increased susceptibility to sexually transmitted infections (STIs) and aerobic vaginitis (Coudray & Madhivanan, 2020, Sex Transm Dis). Therapeutic strategies targeting the vaginal niche include the use of antibiotics to eliminate overgrowing anaerobes, as well as the administration of probiotics or live biotherapeutic products (LBPs) to restore beneficial Lactobacillus populations (Cohen et al., 2020, NEJM). Monitoring the health of this niche often involves assessing biomarkers such as vaginal pH, the Nugent score, and the relative abundance of specific microbial taxa (Petrova et al., 2015, Front Physiol).

Other names
Vaginal microbiomeVaginal microbiotaVaginal ecosystemVaginal microenvironment
02

Mechanism of action

Restoration of commensal microbial populations, acidification of the vaginal environment, competitive inhibition of pathogens, and modulation of the local mucosal immune response.

03

Biological functions

Maintenance of pHPathogen defenseImmune responseEpithelial barrier functionMetabolic homeostasis
04

Disease associations

Bacterial vaginosisInfectionPreterm birthInflammationVulvovaginal candidiasisSexually transmitted infections
05

Safety considerations

Risk of secondary yeast infections following antibiotic useDevelopment of antimicrobial resistancePotential for ascending infections if the niche is severely disruptedVariable colonization success of probiotic strains
06

Interacting drugs

Metronidazole

6 more in the full profile.

07

Biomarkers

Vaginal pHNugent scoreLactobacillus abundanceLactic acid concentrationClue cellsPro-inflammatory cytokines (IL-1beta, IL-8)

Beyond the preview

Go deeper on Vaginal ecological niche.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaginal ecological niche.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call